Table 1.
Effects of 6 months of chromium or combined chromium with vitamins C and E supplementation on anthropometric and laboratory variables
| Placebo (n = 10) | Cr (n = 10) | Cr + C + E (n = 10) | |
|---|---|---|---|
| Men/women (n) | 5/5 | 4/6 | 5/5 |
| Age (years) | 50.5 ± 1.9 | 53.2 ± 2.0 | 51.5 ± 1.7 |
| Body mass index (BMI; kg/m2) | |||
| Baseline | 25.8 ± 0.8 | 25.7 ± 0.9 | 25.7 ± 0.6 |
| 6 months | 25.7 ± 0.7 | 25.6 ± 0.8 | 25.7 ± 1.0 |
| Blood AST (IU/L) | |||
| Baseline | 25.7 ± 2.4 | 24.8 ± 3.3 | 25.1 ± 2.5 |
| 6 months | 25.4 ± 3.1 | 24.1 ± 2.4 | 25.9 ± 3.2 |
| Blood ALT (IU/L) | |||
| Baseline | 31.2 ± 2.8 | 29.1 ± 4.4 | 30.4 ± 2.4 |
| 6 months | 32.1 ± 3.4 | 29.9 ± 2.7 | 30.8 ± 3.5 |
| Blood creatinine (µmol/L) | |||
| Baseline | 70.7 ± 8.8 | 70.7 ± 10.2 | 71.1 ± 8.6 |
| 6 months | 70.4 ± 9.8 | 70.6 ± 8.9 | 70.9 ± 9.5 |
| Blood urea nitrogen (mmol/L) | |||
| Baseline | 5.1 ± 0.4 | 5.4 ± 0.5 | 5.3 ± 0.5 |
| 6 months | 5.4 ± 0.5 | 5.4 ± 0.4 | 5.5 ± 0.5 |
1. Values are the mean ± SD.
2. “*” means significant difference between the placebo group and the Cr or Cr + C + E group.
3. AST: aspartate aminotransferase.
4. ALT: alanine aminotransferase.